UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus

Oncogene, 2006-04, Vol.25 (17), p.2558-2564

2006

Volltextzugriff (PDF)

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data

European journal of cancer (1990), 2016-03, Vol.55, p.147-157

2016

Volltextzugriff (PDF)

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors

Annals of oncology, 2012-09, Vol.23 Suppl 10, p.x173-x177

2012

Volltextzugriff (PDF)

Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma

Journal of clinical pathology, 2006-12, Vol.59 (12), p.1254-1260

2006

Volltextzugriff (PDF)

Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma

American journal of neuroradiology : AJNR, 2015-04, Vol.36 (4), p.763-767

2015

Volltextzugriff (PDF)

Inherited Susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes

JNCI : Journal of the National Cancer Institute, 1999-07, Vol.91 (13), p.1125-1130

1999

Volltextzugriff (PDF)

Genetic Susceptibility to Head and Neck Squamous Cell Carcinoma

JNCI : Journal of the National Cancer Institute, 1996-04, Vol.88 (8), p.530-535

1996

Volltextzugriff (PDF)

TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients

Oral diseases, 2014-09, Vol.20 (6), p.602-608

2014

Volltextzugriff (PDF)

p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma

The Journal of pathology, 1998-04, Vol.184 (4), p.360-368

1998

Volltextzugriff (PDF)

Head and neck cancer: molecular carcinogenesis

Annals of oncology, 2005-06, Vol.16 (suppl-2), p.ii249-ii250

2005

Volltextzugriff (PDF)

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

JNCI : Journal of the National Cancer Institute, 2004-02, Vol.96 (4), p.294-305

2004

Volltextzugriff (PDF)

Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients

Oral diseases, 2013-09, Vol.19 (6), p.577-584

2013

Volltextzugriff (PDF)

Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells

British journal of cancer, 2001-08, Vol.85 (4), p.630-635

2001

Volltextzugriff (PDF)

Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma

Oral diseases, 2013-07, Vol.19 (5), p.452-455

2013

Volltextzugriff (PDF)

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo

British journal of cancer, 1999-01, Vol.79 (1), p.82-88

1999

Volltextzugriff (PDF)

Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus

JNCI : Journal of the National Cancer Institute, 2004-07, Vol.96 (13), p.998-1006

2004

Volltextzugriff (PDF)

Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines

British journal of cancer, 1998-02, Vol.77 (4), p.556-561

1998

Volltextzugriff (PDF)

Preclinical phase II studies in human tumor xenografts: A European multicenter follow-up study

Annals of oncology, 1994-05, Vol.5 (5), p.415-422

1994

Volltextzugriff (PDF)

Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells

Carcinogenesis (New York), 1995-10, Vol.16 (10), p.2395-2400

1995

Volltextzugriff (PDF)

Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines

British journal of cancer, 1997, Vol.76 (2), p.189-197

1997

Volltextzugriff (PDF)

Mutagen Sensitivity as a Biomarker for Second Primary Tumors after Head and Neck Squamous Cell Carcinoma

Cancer epidemiology, biomarkers & prevention, 2000-07, Vol.9 (7), p.713-717

2000

Volltextzugriff (PDF)

Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications

Clinical cancer research, 2001-06, Vol.7 (6), p.1523-1532

2001

Volltextzugriff (PDF)

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (gemcitabine) against human head and neck cancer

Cancer research (Chicago, Ill.), 1991, Vol.51 (1), p.211-214

1991

Volltextzugriff (PDF)

Increased mutagen sensitivity in head‐and‐neck squamous‐cell carcinoma patients, particularly those with multiple primary tumors

International journal of cancer, 1994-03, Vol.56 (6), p.816-819

1994

Volltextzugriff (PDF)

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors

Cancer chemotherapy and pharmacology, 1996, Vol.38 (4), p.335-342

1996

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(138)

Sprache

Englisch
(136)
Japanisch
(20)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(104)
Humans
(103)
Biological And Medical Sciences
(77)
Medical Sciences
(75)
Oncology
(65)
Female
(64)
Animals
(41)
Male
(40)
Pharmacology. Drug Treatments
(37)
Mice
(36)
Antineoplastic Agents
(35)
Tumors
(35)
Mice, Nude
(33)
Middle Aged
(31)
Adult
(30)
Otorhinolaryngology
(29)
Aged
(28)
Carcinoma, Squamous Cell - Genetics
(28)
Head And Neck Neoplasms - Drug Therapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors

Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma

Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma

Inherited Susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes

Genetic Susceptibility to Head and Neck Squamous Cell Carcinoma

TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients

p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma

Head and neck cancer: molecular carcinogenesis

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients

Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells

Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo

Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus

Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines

Preclinical phase II studies in human tumor xenografts: A European multicenter follow-up study

Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells

Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines

Mutagen Sensitivity as a Biomarker for Second Primary Tumors after Head and Neck Squamous Cell Carcinoma

Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (gemcitabine) against human head and neck cancer

Increased mutagen sensitivity in head‐and‐neck squamous‐cell carcinoma patients, particularly those with multiple primary tumors

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors

Suchergebnisse filtern